Quantitative thermophoretic study of disease-related protein aggregates

 

Manuel Wolff , Judith J. Mittag, Therese W. Herling, Erwin De Genst, Christopher M. Dobson, Tuomas P. J. Knowles, Dieter Braun & Alexander K. Buell

Scientific Reports
2016 vol: 6 article number: 22829 doi: 10.1038/srep22829

Abstract
Amyloid fibrils are a hallmark of a range of neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases. A detailed understanding of the physico-chemical properties of the different aggregated forms of proteins, and of their interactions with other compounds of diagnostic or therapeutic interest, is crucial for devising effective strategies against such diseases. Protein aggregates are situated at the boundary between soluble and insoluble structures, and are challenging to study because classical biophysical techniques, such as scattering, spectroscopic and calorimetric methods, are not well adapted for their study. Here we present a detailed characterization of the thermophoretic behavior of different forms of the protein α-synuclein, whose aggregation is associated with Parkinson’s disease. Thermophoresis is the directed net diffusional flux of molecules and colloidal particles in a temperature gradient. Because of their low volume requirements and rapidity, analytical methods based on this effect have considerable potential for high throughput screening for drug discovery. In this paper we rationalize and describe in quantitative terms the thermophoretic behavior of monomeric, oligomeric and fibrillar forms of α-synuclein. Furthermore, we demonstrate that microscale thermophoresis (MST) is a valuable method for screening for ligands and binding partners of even such highly challenging samples as supramolecular protein aggregates.

View Publication

Topics: Aggregation, Antibodies, Aromatic compounds, Macromolecular, Screening, Monolith – MicroScale Thermophoresis, MST, Proteins, Publications, Neurodegenerative diseases

 

 

Previous Article
An engineered monomer binding-protein for alpha-syn efficiently inhibits the proliferation of amyloid fibrils
An engineered monomer binding-protein for alpha-syn efficiently inhibits the proliferation of amyloid fibrils

Up next
A small compound targeting prohibitin with potential interest for cognitive deficit rescue in aging mice and tau pathology treatment
A small compound targeting prohibitin with potential interest for cognitive deficit rescue in aging mice and tau pathology treatment

Characterize the molecular mechanisms of neurodegenerative diseases

Learn how